buyModerate
Casdin Capital, LLC bought $3.9M of TSVT
director at 2seventy bio, Inc.. 777,377 shares at an average of $5.02, traded Mar 21, 2024, filed Mar 25, 2024.
Conviction score
50Value
$3.9M
777,377 shares
Holdings after
1,960,000
+66% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$3.9M at market
- +10Relative to holdingsHoldings up 66%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000919574-24-002176, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 21, 2024 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: See footnote | +300,000 | $4.90 | $1.5M | 1,482,623 | Mar 25, 2024 |
| Mar 22, 2024 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: See footnote | +147,377 | $5.12 | $754k | 1,630,000 | Mar 25, 2024 |
| Mar 25, 2024 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: See footnote | +330,000 | $5.07 | $1.7M | 1,960,000 | Mar 25, 2024 |
| Mar 21, 2024 | SOpen-market sale Total Return Swapderivativeindirect: See footnote | -63,151 | $4.72 | $298k | 536,784 | Mar 25, 2024 |
Related signals
Other insiders at 2seventy bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | 2seventy bio, Inc. | Victoria Eatwell Chief Financial Officer | $13k 2,592 shares | -1% | |
| 45Moderate | 2seventy bio, Inc. | William D Baird III President and CEO | $25k 5,092 shares | -0% | |
| 15Weak | 2seventy bio, Inc. | Jessica Snow Chief Operating Officer | $11k 2,298 shares | -1% | |
| 72Notable | 2seventy bio, Inc. | Kynam Global Healthcare Master Fund, LP owner | $80M 16,238,047 shares | -273% | |
| 50Moderate | 2seventy bio, Inc. | William D Baird III President and CEO | $95k 32,481 shares | -4% | |
| 37Weak | 2seventy bio, Inc. | Victoria Eatwell Chief Financial Officer | $3,244 1,110 shares | -0% | |
| 43Moderate | 2seventy bio, Inc. | Nick Leschly President and CEO | $255k 86,870 shares | -7% | |
| 10Weak | 2seventy bio, Inc. | Jessica Snow See Remarks | $18k 6,300 shares | -4% | |
| 0Weak | 2seventy bio, Inc. | Jessica Snow See Remarks | $7,393 2,287 shares | -1% | |
| 20Weak | TSVTsell 2seventy bio, Inc. | Marcela V. Maus director | $13k 3,900 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.